Mark Mallon - Dec 6, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Executive Officer, Director
Signature
/s/ Mark W. Mallon
Stock symbol
NEO
Transactions as of
Dec 6, 2021
Transactions value $
$520,710
Form type
4
Date filed
12/6/2021, 03:16 PM
Next filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $521K +17K +30.5% $30.63 72.7K Dec 6, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 151K Dec 6, 2021 Common Stock 151K $49.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.